Loss of chromosome 3q is a prognostic marker in fusion-negative rhabdomyosarcoma

Authors

Carina A Dehner, Washington University School of Medicine in St. Louis
Robert C Bell, Washington University School of Medicine in St. Louis
Yang Cao, Washington University School of Medicine in St. Louis
Kevin He, Washington University School of Medicine in St. Louis
John S A Chrisinger, Washington University School of Medicine in St. Louis
Amy E Armstrong, Washington University School of Medicine in St. Louis
Marielle Yohe, National Institutes of Health
Jack Shern, National Institutes of Health
Angela C Hirbe, Washington University School of Medicine in St. Louis

Journal

JCO Precision Oncology

Publication Date

9-1-2023

Volume

7

First Page

e2300037

Document Type

Open Access Publication

DOI

10.1200/PO.23.00037

Rights and Permissions

Dehner CA, Bell RC, Cao Y, He K, Chrisinger JSA, Armstrong AE, Yohe M, Shern J, Hirbe AC. Loss of Chromosome 3q Is a Prognostic Marker in Fusion-Negative Rhabdomyosarcoma. JCO Precis Oncol. 2023 Sep;7:e2300037. doi: 10.1200/PO.23.00037. Licensed under the Creative Commons Attribution 4.0 License: http://creativecommons.org/licenses/by/4.0/

Recommended Citation

Dehner, Carina A; Bell, Robert C; Cao, Yang; He, Kevin; Chrisinger, John S A; Armstrong, Amy E; Yohe, Marielle; Shern, Jack; and Hirbe, Angela C, "Loss of chromosome 3q is a prognostic marker in fusion-negative rhabdomyosarcoma." JCO Precision Oncology. 7, e2300037 (2023).
https://digitalcommons.wustl.edu/oa_4/2297

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.